| P50 | author | Weiva Sieh | Q98780189 |
| | Natalia Udaltsova | Q114454712 |
| P2093 | author name string | Laurel A Habel | |
| | Gary D Friedman | |
| | Stephan Woditschka | |
| P2860 | cites work | Statins, breast cancer, and an invisible switch? | Q46607275 |
| | Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients | Q46710487 |
| | Serum lipids, lipid-lowering drugs, and the risk of breast cancer | Q46772398 |
| | Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis of epidemiological studies | Q46860240 |
| | Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology | Q52861574 |
| | Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. | Q52998393 |
| | Hormone Receptors as Prognostic Factors in Female: Breast Cancer | Q58244337 |
| | Understanding and treating triple-negative breast cancer | Q24620957 |
| | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 |
| | Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 |
| | Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies | Q28280957 |
| | Cancer statistics, 2009 | Q29547625 |
| | Non-lipid-related effects of statins | Q33924588 |
| | Statins and cancer risk: a meta-analysis | Q34481478 |
| | Statins and risk of cancer: a systematic review and metaanalysis | Q34585294 |
| | Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease | Q35910859 |
| | External validity of randomised controlled trials: "to whom do the results of this trial apply?". | Q36003704 |
| | Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update | Q36014966 |
| | Statin use and breast cancer risk in a large population-based setting | Q36120856 |
| | Statins and cancer prevention | Q36337970 |
| | Statin use and breast cancer: prospective results from the Women's Health Initiative. | Q36480676 |
| | American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q36678853 |
| | Management of breast cancer--Part II. | Q36791451 |
| | Adjusted odds ratios for case-control studies with missing confounder data in controls | Q36855626 |
| | Statins and cancer: A systematic review and meta-analysis | Q37245345 |
| | Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism | Q38517307 |
| | Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study | Q39605778 |
| | Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK. | Q40204582 |
| | Breast cancer growth prevention by statins | Q40236401 |
| | Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database | Q43514165 |
| | Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users | Q44252782 |
| | Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models | Q44381249 |
| | Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells | Q44507023 |
| | Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis | Q45149732 |
| | Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis | Q46131692 |
| P433 | issue | 10 | |
| P304 | page(s) | 2479-2487 | |
| P577 | publication date | 2010-08-20 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Lipophilic statin use and risk of breast cancer subtypes | |
| P478 | volume | 19 | |